THE CYP3A5 GENOTYPE HAS A MARKED IMPACT ON TACROLIMUS PHARMACOKINETICS BUT DOES NOT AFFECT MIDAZOLAM PHARMACOKINETICS IN A LARGE COHORT OF RENAL TRANSPLANT RECIPIENTS

被引：0
|
作者：
de Jonge, H. [1 ]
de Loor, H. [1 ]
Verbeke, K. [2 ]
Vanrenterghem, Y. [1 ]
Kuypers, D. R. [1 ]
机构：
[1] Katholieke Univ Leuven Hosp, Dept Nephrol & Renal Transplantat, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Gastrointestinal Res, Louvain, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [41] IN VIVO CYP3A4-ACTIVITY AND CYP3A5-GENOTYPE PREDICT TACROLIMUS PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS.
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S5 - S5
  • [42] Impact of the CYP3A4*1G Polymorphism and Its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Japanese Renal Transplant Recipients
    Satoh, S.
    Miura, M.
    Kagaya, H.
    Saito, M.
    Numakura, K.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 83 - 83
  • [43] CYP3A5 Polymorphism Effect on Cyclosporine Pharmacokinetics in Living Donor Renal Transplant Recipients: Analysis by Population Pharmacokinetics
    Song, Joohan
    Kim, Myeong Gyu
    Choi, Boyoon
    Han, Na Young
    Yun, Hwi-Yeol
    Yoon, Jeong-Hyun
    Oh, Jung Mi
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1141 - 1151
  • [44] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [45] THE ASSOCIATION OF BODYWEIGHT AND CYP3A5 GENOTYPE WITH TACROLIMUS TROUGH LEVEL IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Tang, Jang-Tao
    Shi, Yun-Ying
    Li, Yi
    Yan, Lin
    Wang, Ting-Li
    Bai, Yang-Juan
    Zou, Yuan-Gao
    Tao, Ye
    Wang, Lan-Lan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 415 - 416
  • [46] Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
    Zuo, Xiao-cong
    Ng, Chee M.
    Barrett, Jeffrey S.
    Luo, Ai-jing
    Zhang, Bi-kui
    Deng, Chen-hui
    Xi, Lan-yan
    Cheng, Ke
    Ming, Ying-zi
    Yang, Guo-ping
    Pei, Qi
    Zhu, Li-jun
    Yuan, Hong
    Liao, Hai-qiang
    Ding, Jun-jie
    Wu, Di
    Zhou, Ya-nan
    Jing, Ning-ning
    Huang, Zhi-jun
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 251 - 261
  • [47] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Burk, Oliver
    Schwab, Matthias
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (12) : 1097 - 1098
  • [48] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Oliver Burk
    Matthias Schwab
    European Journal of Clinical Pharmacology, 2007, 63 : 1097 - 1098
  • [49] Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus
    Chen, J. S.
    Li, L. S.
    Cheng, D. R.
    Ji, S. M.
    Sun, Q. Q.
    Cheng, Z.
    Wen, J. Q.
    Sha, G. Z.
    Liu, Z. H.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1557 - 1561
  • [50] Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Cardiac Transplant Recipients
    Wu, Yanting
    Eadon, Michael T.
    Schenkelberg, Laurie
    Rao, Roopa A.
    Skaar, Todd C.
    Tillman, Emma M.
    Shugg, Tyler A.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 20 - 20
12345